NanoScout

Company Overview

Snapshot

Founded in February 2020 by Sam Weitzman, Yaakov Diminsky, and Yohan Ouzan-Van Der Mark, NanoScout operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing advanced nano-detection technologies.

Business overview

NanoScout develops nano-detection technologies and services, providing scalable solutions for various industries. The company's core offering is a cloud-based artificial intelligence software product designed to identify, resolve, and diagnose issues at the nanoscale. By leveraging cloud AI and proprietary sample preparation protocols, NanoScout performs high-end diagnostics and quality assurance, detecting minute details of pathogens and products to identify impurities or infections. It serves markets requiring fast, accurate, and low-cost nano-morphology testing for diagnostics and quality assurance, operating within the Digital Health and Medical Technologies sector.

Company Intelligence Q&A

What is NanoScout's primary focus?

NanoScout specializes in nano-morphology detection at scale, utilizing cloud-based artificial intelligence to find, solve, and diagnose problems at the nanoscale for various industries.

When was NanoScout founded?

NanoScout was founded in February 2020.

Who are the founders of NanoScout?

NanoScout was co-founded by Sam Weitzman, Yaakov Diminsky, and Yohan Ouzan-Van Der Mark.

What technology does NanoScout use for its diagnostics?

NanoScout combines cloud-based artificial intelligence with proprietary sample preparation protocols to perform high-end diagnostics and quality assurance at the nanoscale.

In which sector does NanoScout primarily operate?

NanoScout operates primarily in the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Digital Medical Diagnostics.